跳至主要内容
临床试验/NCT03631446
NCT03631446已完成不适用

Drug Use-Results Survey on Picoprep® Combination Powder

Ferring Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 1,298 人开始时间: 2017年8月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,298
试验地点
1
主要终点
Bowel cleansing assessment for colonoscopy

研究概览

简要总结

The purpose of this survey is to confirm safety and efficacy with patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who are administered the Picoprep® for cleansing of intestinal contents for preparation of colonoscopy and colorectal surgery.

排除标准

  • 未提供

研究组 & 干预措施

Patients administered Picoprep® for bowel cleansing

Patients administered Sodium Picosulfate, Magnesium Oxide and Citric Acid for bowel cleansing

干预措施: Sodium Picosulfate, Magnesium Oxide and Citric Acid (Drug)

结局指标

主要结局

Bowel cleansing assessment for colonoscopy

时间窗: 48 hours after drug administration

Assessment of each part of large intestine using a bowel cleanliness rating scale

Bowel cleansing assessment for colorectal surgery

时间窗: 48 hours after drug administration

Assessment of each part of large intestine using a bowel cleanliness rating scale

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Drug Use-Results Survey on Picoprep® Combination... | 临床试验